SCHEMBL28499043

SCHEMBL28499043

Cc1cc(F)ncc1-c1cccc(N)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.41
MAPT P10636 2/20 0.35
GRM5 P41594 1/20 0.34
FGFR1 P11362 1/20 0.34
ALOX5AP P20292 4/20 0.33
FEN1 P39748 4/20 0.33
KDM4E B2RXH2 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
CYP3A4 P08684 3/20 0.32
TSHR P16473 1/20 0.32
PIK3CA P42336 1/20 0.32
HSD17B10 Q99714 2/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
UHRF1 Q96T88 1/20 0.32
CYP2A6 P11509 1/20 0.31
CYP2B6 P20813 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAP4K4 O95819 1/20 0.31
LCK P06239 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30615400 0.83 UHRF1 (0.50) CD44MAPTFGFR1KDM4ETDP1
SCHEMBL21463872 0.83 UHRF1 (0.50) CD44MAPTFGFR1KDM4ETDP1
SCHEMBL30615386 0.81 CD44 (0.41) CD44MAPTFGFR1KDM4ETDP1
SCHEMBL21463290 0.81 CD44 (0.41) CD44MAPTFGFR1KDM4ETDP1
SCHEMBL21463467 0.78 NNMT (0.45) CD44MAPTFGFR1KDM4EPIK3CA
SCHEMBL30615694 0.78 NNMT (0.45) CD44MAPTFGFR1KDM4EPIK3CA
SCHEMBL21463762 0.75 CD44 (0.45) CD44GRM5KDM4ETDP1CYP3A4
SCHEMBL27897076 0.71 LCK (0.51) CD44CYP3A4CYP2C19LCKCYP17A1
SCHEMBL2067650 0.70
SCHEMBL25053429 0.70 GRM5 (0.49) GRM5ALOX5APFEN1CYP3A4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 CN disclosed
CN-111868037-A Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2020-10-30 CN disclosed